Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: A case-control study

The Lancet Neurology

Volumn 10, Issue 10, 2011, Pages 898-908

  Ross, Owen A ^a   Soto Ortolaza, Alexandra I ^a   Heckman, Michael G ^b   Aasly, Jan O ^c   Abahuni, Nadine ^d   Annesi, Grazia ^e   Bacon, Justin A ^a   Bardien, Soraya ^f   Bozi, Maria ^g   Brice, Alexis ^h,i,j,k   Brighina, Laura ^l   Van Broeckhoven, Christine ^m,n   Carr, Jonathan ^f   Chartier Harlin, Marie Christine ^i,o   Dardiotis, Efthimios ^p,q   Dickson, Dennis W ^a   Diehl, Nancy N ^b   Elbaz, Alexis ^h,i   Ferrarese, Carlo ^l   Ferraris, Alessandro ^r   Fiske, Brian ^s   Gibson, J Mark ^t   Gibson, Rachel ^u   Hadjigeorgiou, Georgios M ^p,q   Hattori, Nobutaka ^v   Ioannidis, John PA ^w,x   Jasinska Myga, Barbara ^y   Jeon, Beom S ^z   Kim, Yun Joong ^aa   Klein, Christine ^ab   Kruger, Rejko ^ac   Kyratzi, Elli ^ad   Lesage, Suzanne ^h,i,j   Lin, Chin Hsien ^ae   Lynch, Timothy ^af   Maraganore, Demetrius M ^ag   Mellick, George D ^ah   Mutez, Eugénie ^i,o,ai   Nilsson, Christer ^aj   Opala, Grzegorz ^y   Park, Sung Sup ^z   Puschmann, Andreas ^aj,ak   Quattrone, Aldo ^al   Sharma, Manu ^ac   Silburn, Peter A ^am   Sohn, Young Ho ^an   Stefanis, Leonidas ^ad   Tadic, Vera ^ab   Theuns, Jessie ^m,n   Tomiyama, Hiroyuki ^v   Uitti, Ryan J ^b   Valente, Enza Maria ^r   van de Loo, Simone ^d   Vassilatis, Demetrios K ^ad   Vilariño Güell, Carles ^ao   White, Linda R ^c   Wirdefeldt, Karin ^ap   Wszolek, Zbigniew K ^b   Wu, Ruey Meei ^ae   Farrer, Matthew J ^a,ao   more..

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d GOETHE UNIVERSITY   (Germany)

^e INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^f STELLENBOSCH UNIVERSITY   (South Africa)

^g General Hospital of Syros   (Greece)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ INSERM   (France)

^j CNRS   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l SAN GERARDO HOSPITAL   (Italy)

^m DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

ⁿ UNIVERSITY OF ANTWERP   (Belgium)

^o UNIV LILLE   (France)

^p UNIVERSITY OF THESSALY   (Greece)

^q INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^r CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^s THE MICHAEL J FOX FOUNDATION FOR PARKINSON'S RESEARCH   (United States)

^t ROYAL VICTORIA HOSPITAL   (United Kingdom)

^u GLAXOSMITHKLINE   (United Kingdom)

^v JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^w UNIVERSITY OF IOANNINA   (Greece)

^x STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y MEDICAL UNIVERSITY OF SILESIA   (Poland)

^z Seoul National University Hospital   (South Korea)

^aa Hallym University   (South Korea)

^ab UNIVERSITY OF LÜBECK   (Germany)

^ac UNIVERSITY OF TÜBINGEN   (Germany)

^ad BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^ae NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^af UNIVERSITY COLLEGE DUBLIN   (Ireland)

^ag MAYO CLINIC   (United States)

^ah GRIFFITH UNIVERSITY   (Australia)

^ai LILLE UNIVERSITY HOSPITAL   (France)

^aj LUND UNIVERSITY   (Sweden)

^ak LUND UNIVERSITY HOSPITAL   (Sweden)

^al UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^am UNIVERSITY OF QUEENSLAND   (Australia)

^an Yonsei University College of Medicine   (South Korea)

^ao UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^ap KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ADULT; AGED; ARAB; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 80052967403     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70175-2     Document Type: Article

References (34)

1. Dachsel JC, Farrer MJ LRRK2 and Parkinson disease. Arch Neurol 2010, 67:542-547.
2. Nuytemans K, Meeus B, Crosiers D, et al. Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population. Hum Mutat 2009, 30:1054-1061.
3. Lesage S, Condroyer C, Lannuzel A, et al. Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease. J Med Genet 2009, 46:458-464.
4. Mata IF, Kachergus JM, Taylor JP, et al. Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005, 6:171-177.
5. Di Fonzo A, Tassorelli C, De Mari M, et al. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 2006, 14:322-331.
6. Paisan-Ruiz C, Nath P, Washecka N, Gibbs JR, Singleton AB Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls. Hum Mutat 2008, 29:485-490.
7. Farrer M, Ross OA LRRK2-related Parkinson disease. GeneReviews 2006, University of Washington, Seattle, WA, (accessed Aug 22, 2011). http://www.ncbi.nlm.nih.gov/books/NBK1208/.
8. Aasly JO, Vilarino-Guell C, Dachsel JC, et al. Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. Mov Disord 2010, 25:2156-2163.
9. Gonzalez-Fernandez MC, Lezcano E, Ross OA, et al. Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain. Parkinsonism Relat Disord 2007, 13:509-515.
10. Hulihan MM, Ishihara-Paul L, Kachergus J, et al. LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol 2008, 7:591-594.
11. Lesage S, Durr A, Tazir M, et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 2006, 354:422-423.
12. Di Fonzo A, Wu-Chou YH, Lu CS, et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006, 7:133-138.
13. Farrer MJ, Stone JT, Lin CH, et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 2007, 13:89-92.
14. Tan EK, Peng R, Teo YY, et al. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 2010, 31:561-568.
15. Ross OA, Wu YR, Lee MC, et al. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol 2008, 64:88-92.
16. Gelb DJ, Oliver E, Gilman S Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184.
18. DerSimonian R, Laird N Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
19. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
20. Li B, Leal SM Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 2008, 83:311-321.
21. Kumar P, Henikoff S, Ng PC Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protocols 2009, 4:1073-1081.
22. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70:425-434.
23. Dudoit S, van der Laan MJ, Pollard KS Multiple testing. Part I. Single-step procedures for control of general type I error rates. Stat Appl Genet Mol Biol 2004, 3. article 13.
24. Ng PC, Henikoff S SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 2003, 31:3812-3814.
25. Nalls MA, Plagnol V, Hernandez DG, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649.
26. Ioannidis JP Population-wide generalizability of genome-wide discovered associations. J Natl Cancer Inst 2009, 101:1297-1299.
27. Lee BD, Shin JH, Vankampen J, et al. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat Med 2010, 16:998-1000.
28. Panagiotou OA, Evangelou E, Ioannidis JP Genome-wide significant associations for variants with minor allele frequency of 5% or less-an overview: a HuGE review. Am J Epidemiol 2010, 172:869-889.
29. Deng J, Lewis PA, Greggio E, Sluch E, Beilina A, Cookson MR Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci USA 2008, 105:1499-1504.
30. Goldstein DS, Imrich R, Peckham E, et al. Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation. Neurology 2007, 69:1580-1584.
31. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A "silent"polymorphism in the MDR1 gene changes substrate specificity. Science 2007, 315:525-528.
32. Ormond KE, Wheeler MT, Hudgins L, et al. Challenges in the clinical application of whole-genome sequencing. Lancet 2010, 375:1749-1751.
33. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008, 9:356-369.
34. Durbin RM, Abecasis GR, Altshuler DL, et al. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073.